Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Opioid-Sparing Pain Treatment In Myeloma And Lymphoma Patients Undergoing High-Dose Chemotherapy (OPTIMAL-HiChemo): Randomized Controlled Trial

NCT04459416 is registered in ClinicalTrials.gov with Memorial Sloan Kettering Cancer Center as lead sponsor.

NCT NCT04459416
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04459416 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Opioid-Sparing Pain Treatment In Myeloma And Lymphoma Patients Undergoing High-Dose Chemotherapy (OPTIMAL-HiChemo): Randomized Controlled Trial
Lead sponsor
Memorial Sloan Kettering Cancer Center
Phase
Phase 3
Overall status
Active, not recruiting
Start date
June 30, 2020
Completion date
June 30, 2027
Enrollment
299 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

hodgkin disease, multiple myeloma, non-hodgkin lymphoma